JONBUR Research · Initiation
You're reading an earlier report from Oct 13, 2026. See the latest report
Hanmi Science · 008930 · Holding companies
Hanmi Science: Sharp 3-Month Rally, Improving Profits and Ownership-Related Filings
Hanmi Science, a KOSPI-listed holding company, closed at ₩51,600 on 2026-10-12, up 55.9% over three months and 38.2% over one year, with a market cap of about ₩3.5T. Filed financials show higher margins and returns than in 2024, while recent filings and a news headline point to shareholder-related activity and a share seizure.
Written Oct 13, 2026 · Data as of Oct 12, 2026 · 0 views
This is not financial advice. The report does not recommend buying or selling anything.
Thesis
The data supports a picture of improving profitability: operating margin rose from 7.7% in 2024 to 10.2% in 2025 and 12.1% on a trailing basis to H1 2026. The share price has moved well ahead of that, and the stock trades at 23.4x earnings and 3.3x book value, far above the listed peers shown.
The data does not explain why the shares rose 55.9% in three months. Many recent filings relate to major shareholders and insiders, including 5%+ holding reports, trading plans, and a change in the largest shareholder's holdings. A news headline from Chosun Biz (2026-10-13) reports a provisional seizure of shares tied to Shin Dong-kook and a ₩500B mortgage loan. The data gives no further detail on this. Investor flows, foreign ownership and short balance are not available.
Business overview
Hanmi Science is classified as a holding company on KOSPI. It was founded on 1973-06-15 and listed on 1988-06-20, with 68,391,550 listed shares. The CEO listed is 김재교.
Revenue grew from ₩950.2B in 2021 to ₩1.36T in 2025. Trailing revenue to H1 2026 is ₩1.41T. The data does not describe the company's subsidiaries or products. A filing dated 2026-09-30 is titled "Withdrawal of Subsidiary from Holding Company", with no further details in the data.
Every earlier JONBUR Research report and update note on Hanmi Science, with Pro.
Unlock with ProModel estimate of fair value
The valuation model has no estimate for this company yet (not enough data, or no positive value with the base case).
Report history
Source: KRX statistical information